Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2005-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ed0a036160d357ea0f4e7eeddf9454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aab39cab973c89d84ba8c3962d5caae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec855bfca40d86273a791272885ede2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ab62a8d3d95464ef69d005de306ded1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_147111d9496141e5273c056ee9625423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428dd3c532588b896c163ad464c90b4f |
publicationDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2570818-A1 |
titleOfInvention |
Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands |
abstract |
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor. |
priorityDate |
2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |